Last reviewed · How we verify
Autologous chondrocyte transplantation
At a glance
| Generic name | Autologous chondrocyte transplantation |
|---|---|
| Sponsor | Faculdade de Medicina de Petrópolis Faculdade Arthur Sá Earp Neto |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee (NA)
- Long-term Outcome Evaluation of Patients Undergoing Autologous Chondrocyte Transplantation Delivered on Biomaterial
- Comparison of Autologous Chondrocyte Implantation Versus Mosaicoplasty: a Randomized Trial (PHASE3)
- All Autologous Cartilage Regeneration in the Treatment of the Knee Cartilage Defects (NA)
- NOVOCART® Inject Plus for Cartilage Defects of the Knee (PHASE3)
- Phase III Study to Evaluate Safety and Effectiveness of NOVOCART 3D Plus vs. Microfracture in Knee Cartilage Defects (PHASE3)
- Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine (PHASE1, PHASE2)
- Nasal Septum Autologous Chondrocytes Transplantation for Condylar Resorption After Orthognathic Surgery (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |